| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1007/978-1-4615-4811-9_66 |
| P698 | PubMed publication ID | 10500839 |
| P50 | author | Paul S. Gaynon | Q89543105 |
| P2093 | author name string | A L Carrel | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lymphoblastic leukemia | Q18553852 |
| leukemia | Q29496 | ||
| P1104 | number of pages | 13 | |
| P304 | page(s) | 593-605 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Advances in Experimental Medicine and Biology | Q4686385 |
| P1476 | title | Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia | |
| P478 | volume | 457 |
| Q34548873 | A New, Lineage Specific, Autoup-Regulation Mechanism for Human Glucocorticoid Receptor Gene Expression in 697 Pre-B-Acute Lymphoblastic Leukemia Cells |
| Q37060671 | A conserved molecular mechanism is responsible for the auto-up-regulation of glucocorticoid receptor gene promoters |
| Q34026481 | Bim polymorphisms: influence on function and response to treatment in children with acute lymphoblastic leukemia |
| Q37616172 | Caesarean delivery and risk of childhood leukaemia: a pooled analysis from the Childhood Leukemia International Consortium (CLIC). |
| Q43991443 | Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy |
| Q35105929 | Characterization of the MM.1 human multiple myeloma (MM) cell lines: a model system to elucidate the characteristics, behavior, and signaling of steroid-sensitive and -resistant MM cells |
| Q28345814 | Constitutive expression of ectopic c-Myc delays glucocorticoid-evoked apoptosis of human leukemic CEM-C7 cells |
| Q36334968 | Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies |
| Q33828580 | Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial |
| Q44454031 | Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin |
| Q38354846 | Dexamethasone-induced Gene 2 (dig2) Is a Novel Pro-survival Stress Gene Induced Rapidly by Diverse Apoptotic Signals |
| Q34171019 | Dexamethasone-loaded block copolymer nanoparticles induce leukemia cell death and enhance therapeutic efficacy: a novel application in pediatric nanomedicine. |
| Q40728828 | Dexamethasone-resistant human Pre-B leukemia 697 cell line evolving elevation of intracellular glutathione level: an additional resistance mechanism |
| Q50699810 | Diagnostic value of the dual-luciferase report assay for predicting response to glucocorticoid in children with acute lymphoblastic leukemia. |
| Q27649439 | Doubling the Size of the Glucocorticoid Receptor Ligand Binding Pocket by Deacylcortivazol |
| Q34766192 | Early dexamethasone treatment induces placental apoptosis in sheep |
| Q43225747 | Effect of cAMP signaling on expression of glucocorticoid receptor, Bim and Bad in glucocorticoid-sensitive and resistant leukemic and multiple myeloma cells |
| Q58862182 | Effect of dexamethasone on voltage-gated K + channels in Jurkat T-lymphocytes |
| Q37249367 | Etiology of common childhood acute lymphoblastic leukemia: the adrenal hypothesis |
| Q34076994 | Evaluation of the NOD/SCID xenograft model for glucocorticoid-regulated gene expression in childhood B-cell precursor acute lymphoblastic leukemia |
| Q47725035 | Expression levels of hsc70 and hsp60 are developmentally regulated during B-cell maturation and not associated to childhood c-ALL at presentation or relapse |
| Q40643110 | Gene expression profile of human lymphoid CEM cells sensitive and resistant to glucocorticoid-evoked apoptosis |
| Q35314426 | Glucocorticoid elevation of dexamethasone-induced gene 2 (Dig2/RTP801/REDD1) protein mediates autophagy in lymphocytes |
| Q35831218 | Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. |
| Q35664297 | Glucocorticoid-induced cell death is mediated through reduced glucose metabolism in lymphoid leukemia cells |
| Q34609961 | Glucocorticoid-mediated repression of the oncogenic microRNA cluster miR-17~92 contributes to the induction of Bim and initiation of apoptosis |
| Q34825844 | Guanosine nucleotides inhibit different syndromes of PTHrP excess caused by human cancers in vivo |
| Q39725899 | Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia |
| Q28552218 | MEK Inhibition Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells to Dexamethasone through Modulation of mTOR Activity and Stimulation of Autophagy |
| Q37171983 | Molecular mechanisms regulating glucocorticoid sensitivity and resistance |
| Q42137028 | Mouse mammary tumor virus promoter-containing retroviral promoter conversion vectors for gene-directed enzyme prodrug therapy are functional in vitro and in vivo |
| Q37299480 | Pharmacogenetics of the neurodevelopmental impact of anticancer chemotherapy |
| Q36727952 | Pharmacogenomics in pediatric leukemia |
| Q34707586 | Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia |
| Q35382898 | Physiologically Based Pharmacokinetic Modeling of Fluorescently Labeled Block Copolymer Nanoparticles for Controlled Drug Delivery in Leukemia Therapy |
| Q39669154 | Pro-apoptotic protein BIM in apoptosis of glucocorticoid-sensitive and -resistant acute lymphoblastic leukemia CEM cells |
| Q38840559 | Quantitative proteomic analysis reveals maturation as a mechanism underlying glucocorticoid resistance in B lineage ALL and re-sensitization by JNK inhibition |
| Q34502160 | Recent insights into the mechanism of glucocorticosteroid-induced apoptosis |
| Q27683537 | Structures and mechanism for the design of highly potent glucocorticoids |
| Q90573731 | Targeting Bcl-2-IP3 receptor interaction to treat cancer: A novel approach inspired by nearly a century treating cancer with adrenal corticosteroid hormones |
| Q42737828 | Trial Watch: Lenalidomide-based immunochemotherapy |
| Q28082910 | Trial Watch: Proteasomal inhibitors for anticancer therapy |
Search more.